2238 Scopus Results - Jefferson Medical College - Thomas Jefferson University Jefferson

Most Recent Peer-reviewed Publications For Division of Hematology

  1. Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs
  2. Investigations of human platelet-type 12-lipoxygenase: Role of lipoxygenase products in platelet activation
  3. Sickle cell pain: A critical reappraisal
  4. Immunoglobulin therapy and thrombosis: Coincidence or causation?
  5. Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation
  6. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
  7. Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: Is the discrepancy decreasing?
  8. Beyond the definitions of the phenotypic complications of sickle cell disease: An update on management
  9. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1
  10. Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation
  11. Subsite-specific colorectal cancer risk in the colorectal endoscopy era
  12. Rap1-Rac1 circuits potentiate platelet activation
  13. We can do it together: PAR1/PAR2 heterodimer signaling in VSMCs
  14. Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis
  15. Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor
  16. Discovery of potent and selective inhibitors of human platelet-type 12-lipoxygenase
  17. Mild haemorheological changes induced by a moderate endurance exercise in patients with sickle cell anaemia
  18. CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
  19. 12-lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
  20. Transfection of human platelets with short interfering RNA
0